Doke C.R. Wahrer - Concepedia

Concepedia

Author

Doke C.R. Wahrer

Massachusetts General Hospital

Also Known As

D C Wahrer, Doke C. R. Wahrer, Doke C.R. Wahrer, Doke Wahrer

15

Publications

3.5K

Citations

11

H-Index

29

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Center for Cancer Research Dana-Farber Cancer Institute University of Southern California

DC

About

Doke C.R. Wahrer is an author at Massachusetts General Hospital specializing in medicine, molecular genetics, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	2.4K
2	Molecular Genetics	5	5	2.1K
3	Cell Biology	4	4	1.6K
4	Molecular Biology	2	2	710
5	Health Sciences	1	1	35

Doke C.R. Wahrer

×

11

Publications

3.5K

Citations

11

H-Index

	Year	Citations
Heterozygous Germ Line <i>hCHK2</i> Mutations in Li-Fraumeni Syndrome Daphne W. Bell, Jennifer M. Varley, Tara E. Szydlo, Science	1999	899
salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines Nicolas Tapon, Kieran F. Harvey, Daphne W. Bell, Cell Is MutatedDevelopmental BiologyCell Cycle ExitCell DivisionCell Regulation	2002	850
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function Sharon B. Cantor, Daphne W. Bell, Shridar Ganesan, Cell ChromatinGenome InstabilityProtein FunctionChromatin RemodelingDna Repair Function	2001	675
Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines Kenneth H. Moberg, Daphne W. Bell, Doke C.R. Wahrer, Nature Cell RegulationMedicineGeneticsCancer Cell BiologyCyclin E Levels	2001	456
DOCK4, a GTPase Activator, Is Disrupted during Tumorigenesis Vijay Yajnik, Charles Paulding, Raffaella Sordella, Cell MedicineTumor SuppressorCancer BiologyCell BiologyTumor Biology	2003	228
Genetic and functional analysis of <i>CHEK2</i> (<i>CHK2</i>) variants in multiethnic cohorts Daphne W. Bell, Sang Ho Kim, Andrew K. Godwin, International Journal of Cancer	2007	90
Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer Michael G. FitzGerald, Deborah J. Marsh, Doke C.R. Wahrer, Oncogene Breast OncologySomatic VariantMedicineGeneticsInfrequent Cause	1998	68
Heterozygous Germline <i>ATM</i> Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease Kim E. Nichols, Seth Levitz, Kristen E. Shannon, Journal of Clinical Oncology	1999	66
Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer Eunice L. Kwak, Kenneth H. Moberg, Doke C.R. Wahrer, Gynecologic Oncology Infrequent MutationsTumor HeterogeneityMedicineGynecologyPathology	2005	52
Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin Jianmin Zhang, Young‐Han Song, Brian W. Brannigan, Molecular Cancer Research GeneticsPathologyMolecular GeneticsDisease Gene IdentificationFunctional Analysis	2009	35

Page 1